Illustration (
Illustration (

Indonesia's BPOM Issues Emergency Use Authorization for Sinovac's Covid-19 Vaccine

English covid-19 pandemic
Fachri Audhia Hafiez • 11 January 2021 18:00
Jakarta: Indonesia's Food and Drug Monitoring Agency (BPOM) has officially issued the emergency use authorization (EUA) for Sinovac Biotech's covid-19 vaccine.
"BPOM issued the EUA for Coronavac," said BPOM Chairman Penny K Lukito during a virtual press conference here on Monday afternoon.
"This decision was based on comprehensive evaluations and discussions and supported by scientific data and evidence," the BPOM head explained.

Bagaimana tanggapan anda mengenai artikel ini?

Last week, The Indonesian Ulema Council (MUI) has also declared the Sinovac covid-19 vaccine to be used in Indonesia is halal.
The Indonesian government plans to launch the covid-19 vaccination program later this week. President Joko Widodo (Jokowi) is scheduled to get vaccinated on Wednesday. The president will be the first persone to receive covid-19 vaccination in Indonesia.
"Based on trials in Bandung, the efficacy of Coronavac is 65.3 percent. Meanwhile, based on trials in Turkey and Brazil, the efficacy of the vaccine is 91.25 percent and 78 percent, respectively," Penny revealed.

Dapatkan berita terbaru dari kami Ikuti langkah ini untuk mendapatkan notifikasi

unblock notif